While there has always been a significant focus on how to effectively educate and market products to patients and healthcare providers (HCPs) there is another group that pharmaceutical manufacturers, specifically– Medical Affairs and Marketing teams need to reach, educate, and influence: . KOLs, often the most experienced in a therapy area, who also may be…

Commercial launch strategies require research, insight gathering and decision-making for years in advance of FDA submission. These processes involve complex requirements and often involve timelines and project plans that are mapped out across functional teams and their agency partners. As teams move quickly into “launch mode”, there are many potential shifting priorities requiring contingency plans…

Compared to those in other fields, in many ways, life sciences marketers need much more precision when it comes to audience segmentation and targeting. The pharmaceutical brands that they are advertising often have very precise indications, which means the drug’s value and benefits are only relevant to a niche audience. For example, imagine that your…

Today’s Life Science organizations expend significant resources to capture and hold the attention of patients and healthcare providers (HCPs) in the digital ecosystem. In 2022, the average U.S. consumer spent more than eight hours a day consuming digital content. Physicians are among the busiest employees in the US, as well as consumers— some survey findings…

As organizations in life sciences continue to grow and evolve, the strategies they use to reach healthcare providers (HCPs) and patients are following suit. Doctors and patients are inundated with more and more information across digital and traditional channels about relevant diseases, gold-standard treatments, and their various benefits.